Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Medvin Clinical Research, 15627 Imperial Highway
mi
from
La Mirada, CA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Medvin Clinical Research, 15627 Imperial Highway
mi
from
La Mirada, CA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Innovative Medical Research of South Florida, 2999 NE 191 St., Suite 330
mi
from
Aventura, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Innovative Medical Research of South Florida, 2999 NE 191 St., Suite 330
mi
from
Aventura, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research of West Florida
mi
from
Clearwater, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Sunrise Medical Research, Inc. 4700 N. State Road Building A, Suite 111
mi
from
Lauderdale Lakes, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Sunrise Medical Research, Inc. 4700 N. State Road Building A, Suite 111
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Group of Naples, 1064 Goodlette Road
mi
from
Naples, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Group of Naples, 1064 Goodlette Road
mi
from
Naples, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Advanced Research Institute Inc., 7114 Congress Street
mi
from
New Port Richey, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Advanced Research Institute Inc., 7114 Congress Street
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Endoscopic Research, Inc., 1817 North Mills Avenue
mi
from
Orlando, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Endoscopic Research, Inc., 1817 North Mills Avenue
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Advanced Medical Research Center, 1690 Dunlawton Ave., Suite 110
mi
from
Port Orange, FL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Advanced Medical Research Center, 1690 Dunlawton Ave., Suite 110
mi
from
Port Orange, FL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Gastrointestinal Specialists of Georgia PC, 711 Canton Rd. Suite 300
mi
from
Marietta, GA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Gastrointestinal Specialists of Georgia PC, 711 Canton Rd. Suite 300
mi
from
Marietta, GA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
The Carle Foundation, 611 West Park Street
mi
from
Urbana, IL
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
The Carle Foundation, 611 West Park Street
mi
from
Urbana, IL
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center, 720 SW Lane St.
mi
from
Topeka, KA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, 720 SW Lane St.
mi
from
Topeka, KA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Investigative Clinical Research, 612 Ridgely Avenue, Suite 401,
mi
from
Annapolis, MD
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Investigative Clinical Research, 612 Ridgely Avenue, Suite 401,
mi
from
Annapolis, MD
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Chevy Chase Clinical Research, 5550 Friendship Blvd.
mi
from
Chevy Chase, MD
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Chevy Chase Clinical Research, 5550 Friendship Blvd.
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Commonwealth Clinical Studies, 189 Quincy St.
mi
from
Brockton, MA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Commonwealth Clinical Studies, 189 Quincy St.
mi
from
Brockton, MA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Center for Digestive Health
mi
from
Troy, MI
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
West Michigan Clinical Research Center, 2093 Health Dr. SW, Suite 201
mi
from
Wyoming, MI
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
West Michigan Clinical Research Center, 2093 Health Dr. SW, Suite 201
mi
from
Wyoming, MI
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Ehrhardt Clinical Research, LLC, 108 Congress Street
mi
from
Belton, MO
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Ehrhardt Clinical Research, LLC, 108 Congress Street
mi
from
Belton, MO
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Holy Name Medical Center, 718 Teaneck Road
mi
from
Teaneck, NJ
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Holy Name Medical Center, 718 Teaneck Road
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
North Shore Long Island Jewish Medical Group, 600 Northern Boulevard, Suite 111
mi
from
Great Neck, NY
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
North Shore Long Island Jewish Medical Group, 600 Northern Boulevard, Suite 111
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
NYU Langone Long Island , 1000 Northern Boulevard, Suite 160
mi
from
Great Neck, NY
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
NYU Langone Long Island , 1000 Northern Boulevard, Suite 160
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Manhattan Medical Research Practice PLLC, 215 Lexington Avenue, 21st Floor
mi
from
New York, NY
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Manhattan Medical Research Practice PLLC, 215 Lexington Avenue, 21st Floor
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
University of North Carolina Center for inflammatory Bowel Diseases, CB 7080, 130 Mason Farm Road, 4151 Bioinformatics Bldg.
mi
from
Chapel Hill, NC
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Center for inflammatory Bowel Diseases, CB 7080, 130 Mason Farm Road, 4151 Bioinformatics Bldg.
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Ohio GI and Liver Institute, 2925 Vernon Place 100
mi
from
Cincinnati, OH
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Ohio GI and Liver Institute, 2925 Vernon Place 100
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Ohio GI & Liver Institute
mi
from
Cincinnati, OH
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Ohio GI & Liver Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center, 3551 Roger Brooke Drive
mi
from
Fort Sam Houston, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center, 3551 Roger Brooke Drive
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine, 7200 Cambridge Street Suite 180.184, 10th Floor
mi
from
Houston, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine, 7200 Cambridge Street Suite 180.184, 10th Floor
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Sciences Center at Houston, 6431 Fannin Street, Medical School Bldg 4-234
mi
from
Houston, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Sciences Center at Houston, 6431 Fannin Street, Medical School Bldg 4-234
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Spring Gastroenterology Associates, 8901 FM 1960 West
mi
from
Humble, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Spring Gastroenterology Associates, 8901 FM 1960 West
mi
from
Humble, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Gasteroenterology Associates of Northern Virgina, 3028 Javier Road
mi
from
Fairfax, VA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Gasteroenterology Associates of Northern Virgina, 3028 Javier Road
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
McGuire DVAMC, 1201 Broad Rock Boulevard
mi
from
Richmond, VA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
McGuire DVAMC, 1201 Broad Rock Boulevard
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Bankstown Hospital, Level 3, Department of Gastroenterology, Eldridge Road
mi
from
Bankstown,
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Bankstown Hospital, Level 3, Department of Gastroenterology, Eldridge Road
mi
from
Bankstown,
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Del Sol Research Management, 850 N Knob Road
mi
from
Tucson, AZ
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Del Sol Research Management, 850 N Knob Road
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Gastroenterology 2665 North Decatur Road Suite 550
mi
from
Decatur, GA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Gastroenterology 2665 North Decatur Road Suite 550
mi
from
Decatur, GA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
DHAT Research Institute / Digestive Health Associates of Texas 3600 Shire Blvd, Suite 106
mi
from
Richardson, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
DHAT Research Institute / Digestive Health Associates of Texas 3600 Shire Blvd, Suite 106
mi
from
Richardson, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Digestive Disease Center, 621 Camden Street, Suite 202
mi
from
San Antonio, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Digestive Disease Center, 621 Camden Street, Suite 202
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Tyler Research Institute, 1720 S. Beckham
mi
from
Tyler, TX
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Tyler Research Institute, 1720 S. Beckham
mi
from
Tyler, TX
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Ventura Clinical Trials, 1835 Knoll Drive
mi
from
Ventura, CA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Ventura Clinical Trials, 1835 Knoll Drive
mi
from
Ventura, CA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Digestive Care Associates, Inc., 1000 Laurel St.
mi
from
San Carlos, CA
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Digestive Care Associates, Inc., 1000 Laurel St.
mi
from
San Carlos, CA
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
ClinSearch, 6035 Shallowford Road, Suite 109
mi
from
Chattanooga, TN
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
ClinSearch, 6035 Shallowford Road, Suite 109
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
AGA Clinical Research Associates, Inc., 3205 Fire Road
mi
from
Egg Harbor Township, NJ
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
AGA Clinical Research Associates, Inc., 3205 Fire Road
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center, 111 East 210th Street
mi
from
Bronx, NY
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center, 111 East 210th Street
mi
from
Bronx, NY
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
Harbor - University of California Los Angeles Medical Center
mi
from
Torrance, CA
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Harbor - University of California Los Angeles Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
University of Louisville, Division of Surgical Oncology
mi
from
Louisville, KY
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
University of Louisville, Division of Surgical Oncology
mi
from
Louisville, KY
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Removal of the Evolution® Esophageal Stent - Fully Covered
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials